Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ120412050,08
KB100310050,20
PKN73,473,42-1,84
Msft469,25469,440,00
Nokia4,7564,760,17
IBM266,81268,10,00
Mercedes-Benz Group AG51,4751,49-0,16
PFE23,2123,220,00
06.06.2025 10:45:00
Indexy online
AD Index online
select
AD Index online
 

  • 05.06.2025
Stryker (SYK, NY Consolidated)
Závěr k 5.6.2025 Změna (%) Změna (USD) Objem obchodů (ks)
383,10 0,14 0,55 904 813
Premarket06.06.2025 10:00:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
- 366,50 390,00 - - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 06.06.2025
Popis společnosti
Obecné informace
Název společnostiStryker Corp
TickerSYK
Kmenové akcie:Ordinary Shares
RICSYK
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 53 000
Akcie v oběhu k 31.03.2025 382 164 865
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice1941 STRYKER WAY
MěstoPORTAGE
PSČ49002
ZeměUnited States
Kontatní osobaJason Beach
Funkce kontaktní osobyVice President, Investor Relations
Telefon12 693 852 600
Fax12693851062

Business Summary: Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Stryker Corp revenues increased 12% to $5.87B. Net income decreased 17% to $654M. Revenues reflect MedSurg and Neurotechnology segment increase of 13% to $3.51B, Orthopaedics segment increase of 10% to $2.36B, United States segment increase of 13% to $4.44B, International segment increase of 7% to $1.43B. Net income was offset by Corporate and Other segment loss increase of 77% to $774M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Devices & Implants
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical Appliance and Supplies Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Electromedical Apparatus Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICSurgical And Medical Instruments
SICElectromedical Equipment



  • Poslední aktualizace: 06.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerKevin Lobo5901.10.202125.04.2011
Chief Financial Officer, Vice PresidentPreston Wells4801.04.202501.04.2025
Group President - Global Quality and OperationsViju Menon5723.04.201823.04.2018
Group President - MedSurg and NeurotechnologyJ. Andrew Pierce5101.10.202101.10.2021
Group President - Orthopaedics and SpineSpencer Stiles4801.10.202101.10.2021
Chief Human Resources Officer, Vice PresidentM. Kathryn Fink5501.01.2016
Chief Accounting Officer, Vice PresidentWilliam Berry5901.01.2014
Vice President - Chief Corporate Affairs OfficerYin Becker6101.01.2016
Vice President, Chief Legal OfficerRobert Fletcher5422.04.201922.04.2019